TaiMed Biologics Inc Environmental Analytics
Environmental and financial analysis dashboard for TaiMed Biologics Inc. Industry: PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES
Company Overview for TaiMed Biologics Inc
Highlights
Showing data for FY2023
Operational Environmental Cost
$0.62m
Operational Environmental Cost Intensity
3.85%
Total Environmental Cost
$0.74m
Total Environmental Cost Intensity
4.63%
ΔOperational Environmental Cost (2020-2023)
$-0.14m
Decoupling Rate (2020-2023)
-9.29%
Adjusted EBITDA
$-1.42m
Adjusted EBITDA Margin
-8.85%
Environmental cost statement
Showing data for FY2023
| USD MM | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| OPERATIONAL SOCIAL COST OF CARBON | ||||
| -55.82% | 34.84% | -7.46% | ||
| 1.03% | 0.78% | 0.86% | 0.91% | |
| -27.32% | 28.41% | 2.31% | ||
| 1.92% | 2.40% | 2.51% | 2.94% | |
| $1m | $0m | $1m | $1m | |
| -37.30% | 30.00% | -0.19% | ||
| 2.95% | 3.18% | 3.37% | 3.85% | |
| INDIRECT SOCIAL COST OF CARBON | ||||
| N/A | N/A | N/A | ||
| N/A | N/A | N/A | 0.78% | |
| N/A | N/A | N/A | ||
| N/A | N/A | N/A | 4.63% | |
All figures are denominated in millions of USD. USD is the base currency used to monetize, other currency equivalents are calculated using end of year exchange rates. Scope 2: Social Cost of Carbon is calculated using market-based emissions data. | ||||
Environmental cost bridge
Showing data for FY2023
Integrated financial analysis
Highlights
Showing data for FY2023
Adjusted EBITDA Margin
-8.85%
Adjusted EBIT Margin
-40%
EV / Adjusted EBITDA
Company Value: Placeholder
Industry Average: Placeholder
Coming soon
EV / Adjusted EBIT
Company Value: Placeholder
Industry Average: Placeholder
Coming soon
Integrated income statement
Showing data for FY2023
| USD MM | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| INCOME STATEMENT | ||||
$26m | $15m | $18m | $16m | |
| -41.89% | 22.62% | -12.55% | ||
$27m | $26m | $22m | $17m | |
| 105.46% | 174.21% | 118.25% | 105.00% | |
$-1m | $-11m | $-3m | $-1m | |
| -5.46% | -74.21% | -18.25% | -5.00% | |
$-6m | $-17m | $-8m | $-6m | |
| -24.81% | -112.10% | -46.04% | -36.60% | |
| ENVIRONMENTAL COST DATA | ||||
$1m | $0m | $1m | $1m | |
| 2.95% | 3.18% | 3.37% | 3.85% | |
| FINANCIAL DATA ADJUSTED FOR OPERATIONAL ENVIRONMENTAL COST | ||||
$-2m | $-12m | $-4m | $-1m | |
| -8.41% | -77.39% | -21.62% | -8.85% | |
$-7m | $-17m | $-9m | $-6m | |
| -27.75% | -115.29% | -49.41% | -40.45% | |
All figures are denominated in millions of USD. USD is the base currency used to monetize, other currency equivalents are calculated using end of year exchange rates. | ||||
Environmental EBITDA bridge
Showing data for FY2023
Industry benchmark
RESEARCH AND EXPERIMENTAL DEVELOPMENT ON NATURAL SCIENCES AND ENGINEERING
Scope 1 (% of Sales)
0.91%
Scope 2 (% of Sales)
2.94%
Operational Environmental Cost Intensity
3.85%
Scope 3 (% of Sales)
0.78%
Total Environmental Cost Intensity
4.63%
Selected peer group
Showing data for FY2023
NAME | COUNTRY | OPERATIONAL ENV. COST | OPERATIONAL ENV. COST INTENSITY |
|---|---|---|---|
TaiMed Biologics Inc | TW | $1m | 3.85% |
Loading similar companies data...
Industry distribution
Showing data for FY2023
Note: Outliers are calculated using the 1.5 * IQR method, where values outside Q1 - 1.5 * IQR and Q3 + 1.5 * IQR are considered outliers.
Estimated Social Cost of Carbon Scope 3 breakdown
Percentage breakdown of Social Cost of Carbon Scope 3 into various categories
Showing data for FY2023
SCOPE 3 CATEGORY | Company (USD) | Company % | Industry Avg (USD) | Industry Avg % |
|---|---|---|---|---|
Purchased goods (1 & 2) | $0m | 42.08% | N/A | N/A |
Energy-related activities (3) | $0m | 9.57% | N/A | N/A |
Upstream transportation (4) | $0m | 16.59% | N/A | N/A |
Waste (5) | $0m | 1.14% | N/A | N/A |
Business travel (6) | $0m | 0.71% | N/A | N/A |
Commuting (7) | N/A | N/A | N/A | N/A |
Upstream leased assets (8) | N/A | N/A | N/A | N/A |
Downstream transportation (9) | $0m | 10.25% | N/A | N/A |
Processing of products (10) | $0m | 0.03% | N/A | N/A |
Use of products (11) | N/A | N/A | N/A | N/A |
Final treatment of products (12) | $0m | 19.64% | N/A | N/A |
Downstream leased assets (13) | N/A | N/A | N/A | N/A |
Franchises (14) | N/A | N/A | N/A | N/A |
Investments (15) | N/A | N/A | N/A | N/A |
Total | $1m | 100.00% | $0m | 100.00% |
Scope 3 breakdown visualization
Showing data for FY2023